Gene · 8900
Papers2,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma. | J Biomed Sci | 2023 | 37559138 | PubTator, text mining | PubMed |
| In silico transcriptional analysis of asymptomatic and severe COVID-19 patients reveals the susceptibility of severe patients to other comorbidities and non-viral pathological conditions. | Hum Gene (Amst) | 2023 | 37521006 | PubTator, text mining | PubMed |
| The cancer preventive activity and mechanisms of prenylated resveratrol and derivatives. | Curr Res Toxicol | 2023 | 37519844 | PubTator, text mining | PubMed |
| DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers. | Int J Mol Sci | 2023 | 37511475 | PubTator, text mining | PubMed |
| The Role of miRNAs in the Development, Proliferation, and Progression of Endometrial Cancer. | Int J Mol Sci | 2023 | 37511248 | PubTator, text mining | PubMed |
| Targeting SOX18 Transcription Factor Activity by Small-Molecule Inhibitor Sm4 in Non-Small Lung Cancer Cell Lines. | Int J Mol Sci | 2023 | 37511076 | PubTator, text mining | PubMed |
| Aberrant AHRR, ADAMTS2 and FAM184 DNA Methylation: Candidate Biomarkers in the Oral Rinse of Heavy Smokers. | Biomedicines | 2023 | 37509437 | PubTator, text mining | PubMed |
| The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential. | Biomolecules | 2023 | 37509175 | PubTator, text mining | PubMed |
| CEBP-β and PLK1 as Potential Mediators of the Breast Cancer/Obesity Crosstalk: In Vitro and In Silico Analyses. | Nutrients | 2023 | 37447165 | PubTator, text mining | PubMed |
| Incomplete Recovery from the Radiocontrast-Induced Dysregulated Cell Cycle, Adhesion, and Fibrogenesis in Renal Tubular Cells after Radiocontrast (Iohexol) Removal. | Int J Mol Sci | 2023 | 37446141 | PubTator, text mining | PubMed |
| Firing of Replication Origins Is Disturbed by a CDK4/6 Inhibitor in a pRb-Independent Manner. | Int J Mol Sci | 2023 | 37445805 | PubTator, text mining | PubMed |
| Genetic basis of embryo and juvenile physiological responses to salinity changes in freshwater pipefish ( Hippichthys heptagonus). | Zool Res | 2023 | 37443403 | PubTator, text mining | PubMed |
| The bromo-adjacent homology domains of PBRM1 associate with histone tails and contribute to PBAF-mediated gene regulation. | J Biol Chem | 2023 | 37394010 | PubTator, text mining | PubMed |
| Omics Analyses of Stromal Cells from ACM Patients Reveal Alterations in Chromatin Organization and Mitochondrial Homeostasis. | Int J Mol Sci | 2023 | 37373166 | PubTator, text mining | PubMed |
| New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions. | Cancer Metastasis Rev | 2023 | 37368179 | PubTator, text mining | PubMed |
| Design, synthesis, and antitumor efficacy of novel 5-deazaflavin derivatives backed by kinase screening, docking, and ADME studies. | J Enzyme Inhib Med Chem | 2023 | 37341389 | PubTator, text mining | PubMed |
| Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling. | Open Life Sci | 2023 | 37333486 | PubTator, text mining | PubMed |
| DPY30 Promotes Proliferation and Cell Cycle Progression of Colorectal Cancer Cells via Mediating H3K4 Trimethylation. | Int J Med Sci | 2023 | 37324189 | PubTator, text mining | PubMed |
| USP39-mediated deubiquitination of Cyclin B1 promotes tumor cell proliferation and glioma progression. | Transl Oncol | 2023 | 37302347 | PubTator, text mining | PubMed |
| SPINK2 Protein Expression Is an Independent Adverse Prognostic Marker in AML and Is Potentially Implicated in the Regulation of Ferroptosis and Immune Response. | Int J Mol Sci | 2023 | 37298647 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8900/papers?page=8